- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02621749
Cerebral Microembolism in the Critically Ill With Acute Kidney Injury (COMET-AKI)
November 7, 2022 updated by: University Hospital Inselspital, Berne
Cerebral Microembolism in the Critically Ill With Acute Kidney Injury: A Prospective Multi-Center Randomized Controlled Trial Comparing Continuous With Intermittent Renal Replacement Therapy.
The primary objective of this study is to investigate the impact of continuous renal replacement therapy and intermittent renal replacement therapy on microbubble / cerebral microemboli generation in a cohort of critically ill patients with dialysis-dependent acute kidney injury.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bern, Switzerland, 3010
- University Hospital Bern
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- > 18 yrs.
- Signed IC
Exclusion Criteria:
- Heart disease (PFO, ASD, VSD, severe valvular disease)
- Atrial fibrillation
- Cerebrovascular pathology
- Missing temporal bone window
- Allergy to plastic contained in the investigative device (transcranial Doppler)
- Chronic kidney disease
- Pregnancy
- Participation in another study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: CRRT group
the CRRT group receives continuous renal replacement therapy for acute kidney injury
|
Patients receive renal replacement therapy according to institutional standards
Other Names:
|
Active Comparator: IRRT group
the IRRT group receives intermittent renal replacement therapy after termination of CRRT.
|
Patients receive renal replacement therapy according to institutional standards
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cerebral Microembolic Load detected by Transcranial Doppler Ultrasound
Time Frame: During hemodialysis therapy
|
During hemodialysis therapy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Gabor Erdoes, MD, University of Berne
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2017
Primary Completion (Actual)
November 6, 2022
Study Completion (Actual)
November 6, 2022
Study Registration Dates
First Submitted
November 20, 2015
First Submitted That Met QC Criteria
December 1, 2015
First Posted (Estimate)
December 3, 2015
Study Record Updates
Last Update Posted (Actual)
November 14, 2022
Last Update Submitted That Met QC Criteria
November 7, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Kidney Diseases
- Urologic Diseases
- Renal Insufficiency
- Embolism and Thrombosis
- Intracranial Embolism and Thrombosis
- Thromboembolism
- Embolism
- Acute Kidney Injury
- Intracranial Embolism
Other Study ID Numbers
- 199/2015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Embolism
-
First Affiliated Hospital Xi'an Jiaotong UniversityCompletedAcute Ischemic Stroke, Cerebral Embolism and ThrombosisChina
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingCalcified Cerebral EmbolismFrance
-
University Hospital, BonnCompletedAortic Valve Disease | Cerebral StrokeGermany
-
University of ZurichSwiss National Science FoundationUnknownThrombosis | Intracranial EmbolismSwitzerland
-
The First Affiliated Hospital with Nanjing Medical...Second Affiliated Hospital of Nantong University; Jiangsu Taizhou People's...RecruitingAtrial Fibrillation | Left Atrial Appendage Occlusion | Silent Cerebral EmbolismChina
-
University Hospital Inselspital, BerneCompleted
-
National Cerebral and Cardiovascular CenterInstitute of Biomedical Research and Innovation, Kobe, Hyogo, JapanCompletedStroke | Cerebral EmbolismJapan
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Cerebrovascular Disorders | Atrial Fibrillation | Arrhythmia | Cerebrovascular Accident | Thrombophlebitis | Cerebral Embolism and Thrombosis
-
Augusta UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedCerebrovascular Disorders | Hematologic Diseases | Anemia, Sickle Cell | Hemoglobinopathies | Cerebral Embolism and Thrombosis
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCerebrovascular Disorders | Anemia, Sickle Cell | Blood Disease | Cerebral Embolism and Thrombosis
Clinical Trials on Renal replacement therapy
-
Petrovsky National Research Centre of SurgeryRecruitingCardiovascular Diseases | Multiple Organ Failure | Renal Failure AcuteRussian Federation
-
Nanjing Medical UniversityRecruiting
-
University Hospital, Clermont-FerrandCompletedAdults Receiving Renal Replacement TherapyFrance
-
US Department of Veterans AffairsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Inje UniversityCompletedEnd-stage Renal DiseaseKorea, Republic of
-
Radovan UvizlUnknown
-
Chulalongkorn UniversityCompletedAcute Renal FailureThailand
-
AKI Critical Care Research FoundationUnknownContinuous Renal Replacement TherapyUnited States
-
Sunnybrook Health Sciences CentreDialysis Solutions Inc.Completed
-
University of ThessalyRecruitingSepsis | Septic Shock | Renal Replacement Therapy | Aminoglycoside ToxicityGreece